Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens

Br J Clin Pharmacol. 2001 Apr;51(4):355-8. doi: 10.1046/j.1365-2125.2001.01356.x.

Abstract

Aims: To examine the effects of nociceptin (NC) and endomorphin 1 (EM1) on electrical field stimulation (EFS)-induced contractions of the human vas deferens (hVD).

Methods: Concentration-response curves to NC and EM1 were constructed in the absence and in presence of peptidase inhibitors (PI). In some experiments a NC receptor antagonist, [Phe1psi(CH2-NH)Gly2]NC(1-13)NH2 [F/G], 10 microM) or naloxone (1 microM) were included.

Results: All data are mean(95%CI). In the presence of PI, NC inhibited twitches (Emax = 67(44,90)%; pEC50 = 7.28(6.95,7.61)). NC inhibition was sensitive to [F/G]. EM1 also inhibited twitches both in the absence (Emax = 82(73,91)% pEC50 = 7.07(6.92,7.22)) and presence (Emax = 83(76,90)%; pEC50 = 7.00(6.91, 7.09)) of PI. EM1 inhibition was sensitive to naloxone.

Conclusions: These data suggest that hVD express NC and opioid receptors that inhibit neurogenic contractions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Humans
  • In Vitro Techniques
  • Male
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Nociceptin
  • Nociceptin Receptor
  • Oligopeptides / pharmacology*
  • Opioid Peptides / pharmacology*
  • Protease Inhibitors / pharmacology
  • Receptors, Opioid / agonists
  • Receptors, Opioid / metabolism*
  • Vas Deferens / drug effects*
  • Vas Deferens / metabolism
  • Vas Deferens / physiology
  • Vasodilator Agents / pharmacology

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Oligopeptides
  • Opioid Peptides
  • Protease Inhibitors
  • Receptors, Opioid
  • Vasodilator Agents
  • endomorphin 1
  • Naloxone
  • Nociceptin Receptor
  • OPRL1 protein, human